Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aPDT for Peri-implant Disease
NCT04187053Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Feb 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylene blue in peri-implant mucositis, peri-implantitis, sponsored by UTHealth Houston. Started Feb 2020; status: completed.
02
Drugs
methylene blue
03
Conditions
peri-implant mucositisperi-implantitis
Beyond the preview
Go deeper on NCT04187053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187053.